LARISSA ELGUDIN: Open Payments
NPI 1629004387 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 37 payments from 15 companies in 2025. Trend: 2023 $1,501 · 2024 $879 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $124 |
| Alkermes, Inc. | 4 | $94 |
| E.R. Squibb & Sons, L.L.C. | 5 | $78 |
| Lundbeck LLC | 3 | $75 |
| ABBVIE INC. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
Products named: REXULTI, LYBALVI, COBENFY, VRAYLAR, CAPLYTA, Auvelity, AUSTEDO XR, Qelbree.
Industry payments across OH — which companies pay providers there.
